Melanoma in the Era of COVID-19

A video conference showing on a laptop

Date: Monday, April 20, 2020
Time: Noon - 1 p.m. PST

Place: Virtual /Remote Conference

Join us for a virtual roundtable discussion as we delve into the current state of COVID-19 as it pertains to melanoma patients and treatments.

How has this virus affected melanoma providers? What treatments are being prioritized or deprioritized? How has this affected clinical research? What can you do if you cannot be seen by your provider?

A panel of interdisciplinary melanoma experts from OHSU (see full list below) will take on these topics and more, including YOUR questions in a roundtable discussion.

Register and submit your questions for the virtual conference today!


Sancy Leachman, M.D., Ph.D.
Professor and Chair, OHSU Dermatology
Director, Melanoma Program, Knight Cancer Institute
'General' in the War on Melanoma

Anna Bar, M.D.
Associate Professor of Dermatology
Co-director, Mohs micrographic surgery

Elizabeth Berry, M.D.
Assistant Professor of Dermatology
Director, Multidisciplinary Pigmented Lesion Clinic

Dale Han, M.D.
Associate Professor of Surgery
Division of Surgical Oncology

Aimee Kohn, M.D., Ph.D.
Assistant Professor of Medicine
Division of Hematology/Medical Oncology

Rajan Kulkarni, M.D., Ph.D.
Associate Professor of Dermatology
Member, Center For Early Detection Research (CEDAR)

Catherine Morgans, Ph.D.
Associate Professor of Chemical Physiology and Biochemistry

Jone Sampson, M.D.
​​​​​​Professor of Molecular Genetics

Susan Tofte, F.N.P.
Assistant Professor of Dermatology

Alexander Witkowski, M.D., Ph.D.
Assistant Professor of Dermatology
Co-director, Skin Cancer Imaging Center

The Aim at Melanoma logo
This event is endorsed by AIM at Melanoma Foundation